申请人:Doughty Howard Richard
公开号:US20050032823A1
公开(公告)日:2005-02-10
The invention thus provides the compounds of formula (I) and pharmaceutically acceptable salts thereof, in which: R
1
and R
2
are independently selected from the group consisting of H, C
1-6
alkyl, C
2-6
alkenyl, C
3-4
alkynyl, C
3-10
cycloalkylC
0-6
alkyl and C
4-12
bridged cycloalkyl; R
3
is selected from the group consisting of C
1-6
alkyl, NH
2
and R
5
CONH; R
4
is selected from the group consisting of CH
2
F, CHF
2
, CF
3
CH
2
, CF
3
CHF and CF
3
CF
2
; and R
5
is selected from the group consisting of H, C
1-6
alkyl, C
1-6
alkoxy, C
1-6
alkylOC
1-6
alkyl, phenyl, HO
2
cc
1-6
?alkyl, C
1-6
alkylOCOC
1-6
alkyl, C
1-4
alkylOCO, H
2
NC
1-6
alkyl, C
1-6
alkylOCONHC
1-6
alkyl and C
1-6
alkylCONHC
1-6
alkyl. Compounds of formula (I) are potent and selective inhibitors of COX-2 and are of use in the treatment of the pain, fever, inflammation of a variety of conditions and diseases.
因此,本发明提供了式 (I) 化合物及其药学上可接受的盐类,其中:R
1
和 R
2
独立选自由 H、C
1-6
烷基、C
2-6
烯基、C
3-4
炔基,C
3-10
环烷基C
0-6
烷基和 C
4-12
桥环烷基;R
3
选自由 C
1-6
烷基、NH
2
和 R
5
CONH; R
4
选自 CH
2
F、CHF
2
、CF
3
CH
2
CF
3
CHF 和 CF
3
CF
2
和 R
5
选自 H、C
1-6
烷基、C
1-6
烷氧基、C
1-6
烷基OC
1-6
烷基、苯基、HO
2
cc
1-6
烷基、C
1-6
烷基 OCOC
1-6
烷基,C
1-4
烷基OCO,H
2
NC
1-6
烷基,C
1-6
烷基 OCONHC
1-6
烷基和 C
1-6
烷基CONHC
1-6
烷基。式(I)化合物是 COX-2 的强效选择性抑制剂,可用于治疗各种病症和疾病的疼痛、发热和炎症。